I-Mab Biopharma
IMAB
#9469
Rank
C$78.79 M
Marketcap
$0.97
Share price
-6.87%
Change (1 day)
-61.13%
Change (1 year)

I-Mab Biopharma (IMAB) - Total debt

Total debt on the balance sheet as of September 2024 : C$5.37 Million

According to I-Mab Biopharma's latest financial reports the company's total debt is C$5.37 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

I-Mab Biopharma - Total debt on balance sheet (from 2024 to 2023)

Total debt by year

Year Total debt Change
2023-12-31C$3.54 M65.72%
2022-12-31C$2.13 M-39.4%
2021-12-31C$3.52 M767.06%
2020-12-31C$0.4 M-88.51%
2019-12-31C$3.54 M-16.37%
2018-12-31C$4.23 M-32.86%
2017-12-31C$6.3 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.71 B 13,241.55%๐Ÿ‡บ๐Ÿ‡ธ USA